• Depleted SOX-2 via targeting the FBXW2-MSX2 axis• Suppressed CSC properties• Sensitized breast cancer cells to tamoxifen• Combination with 5-AZA increased DNA-damage, cell death and complete xenograft tumor regression. The gene discussed is MSX2; the disease is breast carcinoma.